Prothena Corp Public (PRTA) Intangibles (2012 - 2013)
Prothena Corp Public (PRTA) recorded quarterly Intangibles of $44000.0 in Q1 2013, down 10.2% quarter-over-quarter from $49000.0 in Q4 2012.
Prothena Corp Public (PRTA) Intangibles (2012 - 2013) Analysis & Trends
Prothena Corp Public's Intangibles history runs 2 years deep, the most recent figure standing at $44000.0 for Q1 2013.
- In Q1 2013, Intangibles changed N/A year-over-year to $44000.0; the TTM figure through Mar 2013 stood at $44000.0 (changed N/A YoY), while the FY2012 annual figure was $49000.0, changed N/A from the prior year.
- Intangibles was $44000.0 for Q1 2013 at Prothena Corp Public, down from $49000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $49000.0 in Q4 2012 to a low of $44000.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 44,000.00 |
| Dec 31, 2012 | 49,000.00 |